FIMANAC Trademark

Trademark Overview


On Thursday, March 4, 2021, a trademark application was filed for FIMANAC with the United States Patent and Trademark Office. The USPTO has given the FIMANAC trademark a serial number of 79307666. The federal status of this trademark filing is REGISTERED as of Tuesday, October 11, 2022. This trademark is owned by PCI Biotech AS. The FIMANAC trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical and veterinary preparations for the treatment of cancer, for the treatment of a variety of skin conditions, for wound healing, for the treatment of eye diseases and conditions; pharmaceutical drugs being for treatment of cancer, treatment of skin conditions, treatment of wounds, treatment of eye diseases and conditions; cancer medicines, medicines for skin conditions, medicines for wound healing, medicines for eye diseases and conditions; vaccines; preventive vaccines; vaccine preparations; vaccine aids being vaccine preparations; vaccine adjuvants; pharmaceutical preparations for the treatment of cancer; pharmaceutical products being preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; nucleic acid sequences for medical and veterinary purposes; therapeutic drugs and agents for cancer treatment, for the treatment of a variety of skin conditions, for wound healing...

Surgical apparatus and instruments; medical apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; veterinary apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; medical equipment for skin and tissue illumination; LED (light-emitting diode) lamps for medical use; LED (light-emitting diode) light sources for medical use; treatment lamps for medical purposes, namely light-induced therapy for cancer treatment, light-induced therapy for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; lasers for medical use
fimanac

General Information


Serial Number79307666
Word MarkFIMANAC
Filing DateThursday, March 4, 2021
Status700 - REGISTERED
Status DateTuesday, October 11, 2022
Registration Number6868210
Registration DateTuesday, October 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Certificate of Correction for RegistrationIn the statement, class 5 has been corrected per the Restriction, and per the Fnote dated 01/05/2023.
Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cancer, for the treatment of a variety of skin conditions, for wound healing, for the treatment of eye diseases and conditions; pharmaceutical drugs being for treatment of cancer, treatment of skin conditions, treatment of wounds, treatment of eye diseases and conditions; cancer medicines, medicines for skin conditions, medicines for wound healing, medicines for eye diseases and conditions; vaccines; preventive vaccines; vaccine preparations; vaccine aids being vaccine preparations; vaccine adjuvants; pharmaceutical preparations for the treatment of cancer; pharmaceutical products being preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; nucleic acid sequences for medical and veterinary purposes; therapeutic drugs and agents for cancer treatment, for the treatment of a variety of skin conditions, for wound healing, for the treatment of eye diseases and conditions * ; none of the aforementioned products being ophthalmic pharmaceutical preparations for the treatment of inflammation *
Translation of Words in MarkThe wording "FIMANAC" has no meaning in a foreign language.
Goods and ServicesSurgical apparatus and instruments; medical apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; veterinary apparatus and instruments for treatment of cancer, for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; medical equipment for skin and tissue illumination; LED (light-emitting diode) lamps for medical use; LED (light-emitting diode) light sources for medical use; treatment lamps for medical purposes, namely light-induced therapy for cancer treatment, light-induced therapy for the treatment of a variety of skin conditions, for the treatment of wounds, for the treatment of eye diseases and conditions; lasers for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 2, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePCI Biotech AS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNO

Party NamePCI Biotech AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNO

Party NamePCI Biotech AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNO

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, September 22, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, September 22, 2023INVALIDATION PROCESSED
Monday, September 11, 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, February 20, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 14, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Monday, January 30, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, January 30, 2023FINAL DISPOSITION PROCESSED
Wednesday, January 11, 2023LIMITATION FROM THE IB EXAMINED AND ENTERED
Wednesday, January 11, 2023CORRECTION UNDER SECTION 7 ¿ PROCESSED
Wednesday, January 11, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 11, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 11, 2022REGISTERED-PRINCIPAL REGISTER
Monday, September 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, September 4, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Saturday, August 27, 2022LIMITATION OF GOODS RECEIVED FROM IB
Monday, May 9, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 5, 2021REFUSAL PROCESSED BY IB
Thursday, October 14, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, October 14, 2021REFUSAL PROCESSED BY MPU
Wednesday, September 29, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 28, 2021NON-FINAL ACTION WRITTEN
Monday, September 27, 2021ASSIGNED TO EXAMINER
Tuesday, April 6, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 1, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB